1 Min Read
April 9 (Reuters) - Abzena PLC:
* GOT NOTICE FROM HALOZYME THERAPEUTICS OF TERMINATION OF COLLABORATION, LICENCE AGREEMENT RELATING TO HALOZYME’S USE OF CO’S THIOBRIDGE LINKER TECH Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.